Sepantronium bromide (YM155) improves daratumumab-mediated cellular lysis of multiple myeloma cells by abrogation of bone marrow stromal cell-induced resistance
Files
Publication date
2016-08
Authors
de Haart, Sanne J.
Holthof, Lisa
Noort, Willy A
Minnema, Monique
Emmelot, Maarten E
Aarts-Riemens, Tineke
Doshi, Parul
Sasser, Kate
Yuan, Huipin
de Bruijn, Joost
Editors
Advisors
Supervisors
Document Type
Comment
Metadata
Show full item recordCollections
License
Abstract
Keywords
Letter
Citation
de Haart, S J, Holthof, L, Noort, W A, Minnema, M C, Emmelot, M E, Aarts-Riemens, T, Doshi, P, Sasser, K, Yuan, H, de Bruijn, J, Martens, A C M, van de Donk, N W C J, Lokhorst, H M, Groen, R W J & Mutis, T 2016, 'Sepantronium bromide (YM155) improves daratumumab-mediated cellular lysis of multiple myeloma cells by abrogation of bone marrow stromal cell-induced resistance', Haematologica, vol. 101, no. 8, pp. e339-e342. https://doi.org/10.3324/haematol.2015.139667